Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pulmonology

Symptoms, Exacerbations & Warning Signs

At a Glance

The key to managing idiopathic bronchiectasis is distinguishing your daily baseline cough and mucus production from a flare-up. A flare involves three or more worsening symptoms, like changes in mucus color or increased shortness of breath, lasting over 48 hours and requires prompt treatment.

Living with idiopathic bronchiectasis requires becoming an expert on your own body. Because the condition is chronic, a “normal” baseline may involve some daily coughing or mucus production. The key to long-term health is learning to distinguish these daily symptoms from a pulmonary exacerbation, often called a “flare-up” [1][2].

Your Daily Baseline

Most people with bronchiectasis experience two primary hallmark symptoms every day:

  • Chronic Productive Cough: A persistent cough that often brings up sputum (mucus) [1].
  • Sputum Production: This mucus can vary in color and thickness. Knowing your “baseline” color (e.g., clear, white, or pale yellow) is essential for spotting changes [2][3].

Patients may also experience dyspnea (shortness of breath), which often correlates with the severity of the airway widening in the lungs [4].

Recognizing a Flare (Exacerbation)

A flare is more than just a bad day; it is a clinical deterioration that usually requires a change in treatment [3]. According to international consensus, a flare is defined by having three or more of the following symptoms for at least 48 hours:

  1. Increased Sputum Volume: Coughing up significantly more mucus than usual [3].
  2. Sputum Purulence: The color of the mucus changes (e.g., turning from clear to dark green or rust-colored) or it becomes thicker and harder to clear [3].
  3. Increased Cough: The cough becomes more frequent, forceful, or painful [3].
  4. Increased Shortness of Breath: Feeling winded doing activities that were previously easy [3].
  5. Systemic Malaise: A general sense of being unwell, which may include extreme fatigue, “brain fog,” or a low-grade fever [3].
  6. Hemoptysis: Seeing blood in the mucus [3]. Safety Note: Small streaks of blood in the sputum are common during a flare and warrant a call to a pulmonologist. However, coughing up larger amounts of blood (tablespoons or cupfuls) is a medical emergency requiring immediate hospital care.

Common Triggers

Flares do not always happen for no reason. Common triggers that can kick-start the “vicious cycle” include:

  • Infections: Viral infections (like the common cold, flu, or COVID-19) often lead to secondary bacterial infections [5][6].
  • GERD (Acid Reflux): If stomach acid or food particles travel up the esophagus and are accidentally inhaled (aspiration), they can cause intense inflammation in the lungs [7][8]. Simple lifestyle changes, such as elevating the head while sleeping or not eating within three hours of bedtime, are often recommended to help prevent this.
  • Environmental Factors: Sudden drops in temperature or high levels of air pollution (like SO2) can irritate sensitive airways [9][10].
  • Co-existing Conditions: Untreated asthma, COPD, or sleep apnea can make the lungs more vulnerable to flares [11][12].

Why Early Detection Matters

Catching a flare early is the best way to protect the lungs. Each severe flare can lead to more inflammation, causing further permanent scarring and widening of the airways [13][14]. Over time, frequent flares are linked to a decline in lung function and a higher risk of other health complications [15][16].

Recognizing warning signs—such as a shift in mucus color or a sudden heaviness in the chest—allows for immediate treatment to “break the cycle” before it causes lasting damage [17][18]. Many doctors provide a “rescue pack” of antibiotics and a sputum collection kit to keep at home so patients can begin treatment the moment a flare is recognized.

Common questions in this guide

What is a bronchiectasis flare-up?
A flare-up, or pulmonary exacerbation, is a clinical deterioration involving three or more worsening symptoms for at least 48 hours. These typically include increased coughing, more mucus production, changes in mucus color, shortness of breath, or fatigue.
What triggers an idiopathic bronchiectasis exacerbation?
Flare-ups can be triggered by respiratory infections like the common cold or flu, acid reflux (GERD), sudden temperature drops, and high air pollution. Untreated co-existing conditions like asthma or sleep apnea can also make your lungs more vulnerable to exacerbations.
How can I tell the difference between my normal symptoms and a flare-up?
Knowing your daily baseline, such as your typical mucus color and cough frequency, helps you spot a flare-up. A flare-up involves a noticeable change, such as mucus turning dark green or rust-colored, becoming thicker, or experiencing sudden chest heaviness and severe fatigue.
What is a rescue pack for bronchiectasis?
A rescue pack is a proactive prescription typically containing antibiotics and a sputum collection kit that your doctor provides for you to keep at home. This allows you to start treatment immediately at the first sign of a flare-up to prevent lasting lung damage.
When does coughing up blood become a medical emergency?
While small streaks of blood in your mucus are common during a flare-up and warrant a call to your doctor, coughing up larger amounts, such as tablespoons or cupfuls, is a medical emergency that requires immediate hospital care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What should my 'baseline' look like, and how will we know when a change in my symptoms requires a new prescription?
  2. 2.Can I have a 'rescue pack' of antibiotics and a sputum collection kit at home to use at the first sign of a flare?
  3. 3.Should I be screened for GERD (reflux) or sleep apnea, as these might be triggering my lung symptoms?
  4. 4.How should I adjust my airway clearance routine (physiotherapy) when I feel a flare starting?
  5. 5.At what point do my symptoms become an emergency that requires a visit to the hospital?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.

    Satırer O, Mete Yesil A, Emiralioglu N, et al.

    Respiratory medicine 2018; (137()):35-39 doi:10.1016/j.rmed.2018.02.013.

    PMID: 29605210
  2. 2

    Non-CF bronchiectasis: Orphan disease no longer.

    Imam JS, Duarte AG

    Respiratory medicine 2020; (166()):105940 doi:10.1016/j.rmed.2020.105940.

    PMID: 32250872
  3. 3

    Bronchiectasis.

    McShane PJ, Tino G

    Chest 2019; (155(4)):825-833 doi:10.1016/j.chest.2018.10.027.

    PMID: 30403962
  4. 4

    Correlation among clinical, functional and morphological indexes of the respiratory system in non-cystic fibrosis bronchiectasis patients.

    Perossi J, Koenigkam-Santos M, Perossi L, et al.

    PloS one 2022; (17(7)):e0269897 doi:10.1371/journal.pone.0269897.

    PMID: 35793286
  5. 5

    Sputum pathogen spectrum and clinical outcomes of upper respiratory tract infection in bronchiectasis exacerbation: a prospective cohort study.

    Huang Y, Chen CL, Cen LJ, et al.

    Emerging microbes & infections 2023; (12(1)):2202277 doi:10.1080/22221751.2023.2202277.

    PMID: 37038356
  6. 6

    The microbiome in bronchiectasis.

    Richardson H, Dicker AJ, Barclay H, Chalmers JD

    European respiratory review : an official journal of the European Respiratory Society 2019; (28(153)) doi:10.1183/16000617.0048-2019.

    PMID: 31484665
  7. 7

    Ancillary treatment of patients with lung disease due to non-tuberculous mycobacteria: a narrative review.

    Youssefnia A, Pierre A, Hoder JM, et al.

    Journal of thoracic disease 2022; (14(9)):3575-3597 doi:10.21037/jtd-22-410.

    PMID: 36245600
  8. 8

    Association between gastroesophageal reflux disease and incident bronchiectasis: a nationwide representative population-based study in Korea.

    Yoon J, Yoon JH, Lee H, et al.

    BMC pulmonary medicine 2025; (26(1)):7 doi:10.1186/s12890-025-04011-2.

    PMID: 41327280
  9. 9

    Association between environmental factors and hospitalisations for bronchiectasis in Badalona, Barcelona, Spain (2007-2015).

    Garcia-Olivé I, Radua J, Sánchez-Berenguer D, et al.

    Medicina clinica 2018; (150(7)):257-261 doi:10.1016/j.medcli.2017.06.022.

    PMID: 28755827
  10. 10

    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.

    Gao YH, Guan WJ, Chen RC, Zhang GJ

    The European respiratory journal 2016; (48(4)):1246-1247 doi:10.1183/13993003.00780-2016.

    PMID: 27694413
  11. 11

    Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC).

    Polverino E, Dimakou K, Traversi L, et al.

    The Journal of allergy and clinical immunology 2024; (153(6)):1553-1562 doi:10.1016/j.jaci.2024.01.027.

    PMID: 38401857
  12. 12

    Bronchiectasis in severe asthma: Clinical features and outcomes.

    Coman I, Pola-Bibián B, Barranco P, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2018; (120(4)):409-413 doi:10.1016/j.anai.2018.02.016.

    PMID: 29496464
  13. 13

    Non-Cystic Fibrosis Bronchiectasis in Adults: A Review.

    Barker AF, Karamooz E

    JAMA 2025; (334(3)):253-264 doi:10.1001/jama.2025.2680.

    PMID: 40293759
  14. 14

    Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis.

    Hsieh MH, Lin CY, Wang CY, et al.

    Infection and drug resistance 2018; (11()):1137-1143 doi:10.2147/IDR.S169789.

    PMID: 30127630
  15. 15

    Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.

    Li W, Qin Z, Gao J, et al.

    Chronic respiratory disease 2019; (16()):1479972318790269 doi:10.1177/1479972318790269.

    PMID: 30101613
  16. 16

    [Bronchiectasis not due to cystic fibrosis].

    Girón R, Golpe R, Martínez-García MÁ

    Medicina clinica 2024; (163(2)):81-90 doi:10.1016/j.medcli.2024.01.023.

    PMID: 38637217
  17. 17

    Bronchiectasis management in adults: state of the art and future directions.

    Choi H, McShane PJ, Aliberti S, Chalmers JD

    The European respiratory journal 2024; (63(6)) doi:10.1183/13993003.00518-2024.

    PMID: 38782469
  18. 18

    Pharmacotherapeutic strategies for treating bronchiectasis in pediatric patients.

    Lee E, Hong SJ

    Expert opinion on pharmacotherapy 2019; (20(8)):1025-1036 doi:10.1080/14656566.2019.1589453.

    PMID: 30897021

This page explains idiopathic bronchiectasis symptoms and flare-ups for educational purposes only. Always consult your pulmonologist to establish a personalized emergency action plan for exacerbations.

Get notified when new evidence is published on Idiopathic bronchiectasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.